Immunopathogenesis and therapy of cutaneous T cell lymphoma

Míreanna Comhchosúla

• Immunopathogenesis and therapy of cutaneous T cell lymphoma
  le: Kim, Ellen J., et al.
  Foilsithe: (2005)
• Inhibition of Cell-Mediated Immunity by the Histone Deacetylase Inhibitor Vorinostat:Implications for Therapy of Cutaneous T-Cell Lymphoma
  le: Stephen, Sasha, et al.
  Foilsithe: (2011)
• Increased Programmed Death-1 Expression on CD4(+) T Cells in Cutaneous T-Cell Lymphoma: Implications for Immune Suppression
  le: Samimi, Sara, et al.
  Foilsithe: (2010)
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches
  le: Weiner, David M., et al.
  Foilsithe: (2020)
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication
  le: Durgin, Joseph S., et al.
  Foilsithe: (2020)